Physician profile
Daniel Marcus
NPI 1417061714
$43,208.75
in general payments reported to CMS, 2019-2025
20 companies · $11K in 2025
The $11K reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $729 · 2021: $1,068 · 2022: $1,889 · 2023: $6,800 · 2024: $683 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $14K · Food and Beverage: $3,123 · Travel and Lodging: $1,208 · Consulting Fee: $40.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $13,750.00 |
| Food and Beverage | $3,122.76 |
| Travel and Lodging | $1,208.43 |
| Consulting Fee | $40.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $28,258.79 | 2019-2025 | |
| Covidien Lp | $10,975.21 | 2019-2020 | |
| Medtronic, INC. | $2,514.05 | 2021-2025 | Transorb, Progrip, Signia |
| New Wave Endo-Surgical Corp. | $464.00 | 2022 | |
| Ethicon US, LLC | $379.93 | 2019-2022 | |
| Davol INC. | $99.24 | 2020-2022 | |
| Acell, INC. | $76.08 | 2019-2020 | |
| Kci USA, INC. | $67.83 | 2021-2023 | V.A.C. Veraflo, Activ.A.C. |
| Vertex Pharmaceuticals Incorporated | $56.39 | 2025 | |
| Stryker Corporation | $53.28 | 2021 | |
| W. L. Gore & Associates, INC. | $46.36 | 2024-2025 | Gore Synecor Biomaterial |
| Solventum Corporation | $42.85 | 2025 | V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice, Activ.A.C. |
| Smith+Nephew, INC. | $37.12 | 2022 | |
| Boston Scientific Corporation | $32.29 | 2021 | |
| Convatec INC. | $23.18 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $22.67 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $19.02 | 2023 | Seglentis |
| Pacira Pharmaceuticals Incorporated | $14.56 | 2024 | Exparel |
| Biotissue Holdings INC. | $13.41 | 2024 | |
| Integra Lifesciences Corporation | $12.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Marcus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.